relative to the substitution of biological products.
HB 117 regulates automatic substitution of biologic medications in New Hampshire, requiring notification and likely limiting interchangeable product switches to protect treatment continuity.
HB 117 regulates automatic substitution of biologic medications in New Hampshire, requiring notification and likely limiting interchangeable product switches to protect treatment continuity.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Bill text & amendments